Protective Factors against Fear of Cancer Recurrence in Breast Cancer Patients: A Latent Growth Model.

BOUNCE breast cancer coping self-efficacy fear of cancer recurrence latent growth modeling trajectories

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
15 Sep 2023
Historique:
received: 08 08 2023
revised: 03 09 2023
accepted: 11 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

The current study aimed to examine the fear of cancer recurrence (FCR) trajectory and protective predictors in women coping with breast cancer (BC). The study's model investigated whether a higher coping self-efficacy and positive cognitive-emotion regulation at the time of the BC diagnosis would lead to reduced levels of FCR at six months and in later stages (12 and 18 months) post-diagnosis. The sample included 494 women with stages I to III BC from Finland, Italy, Portugal, and Israel. They completed self-report questionnaires, including the Fear of Cancer Recurrence Inventory (FCRI-SF), the Cancer Behavior Inventory-Brief Version (CBI-B), the Cognitive-Emotion Regulation Questionnaire (CERQ short), and medical-social-demographic data. Findings revealed that a higher coping self-efficacy at diagnosis predicted lower FCR levels after six months but did not impact the FCR trajectory over time. Surprisingly, positive cognitive-emotion regulation did not predict FCR levels or changes over 18 months. FCR levels remained stable from six to 18 months post-diagnosis. This study emphasizes the importance of developing specific cancer coping skills, such as coping self-efficacy. Enhancing coping self-efficacy in the first six months after BC diagnosis may lead to lower FCR levels later, as FCR tends to persist in the following year.

Identifiants

pubmed: 37760558
pii: cancers15184590
doi: 10.3390/cancers15184590
pmc: PMC10526521
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Union's Horizon 2020 Research and Innovation Programme
ID : 777167
Organisme : Canadian Friends of the Hebrew University (CFHU) Fellowship Fund

Références

Psychooncology. 2022 Jun;31(6):879-892
pubmed: 35388525
Oncol Nurs Forum. 2012 May 1;39(3):287-95
pubmed: 22543387
J Cancer Surviv. 2015 Mar;9(1):68-79
pubmed: 25135205
Psychooncology. 2007 Mar;16(3):171-80
pubmed: 16858670
J Transcult Nurs. 2019 Mar;30(2):146-153
pubmed: 29708040
Psychooncology. 2007 Apr;16(4):329-41
pubmed: 16888704
Psychooncology. 2021 Sep;30(9):1555-1562
pubmed: 33998100
Support Care Cancer. 2016 Oct;24(10):4207-18
pubmed: 27169700
Cancer Res Treat. 2022 Oct;54(4):1065-1073
pubmed: 34883553
Singapore Med J. 2021 Jun;62(6):305-310
pubmed: 31989183
Clin Psychol Rev. 2019 Mar;68:13-24
pubmed: 30617013
J Psychosom Res. 2023 Mar;166:111177
pubmed: 36739729
BMC Cancer. 2018 Oct 20;18(1):1002
pubmed: 30342495
Int J Environ Res Public Health. 2022 Sep 30;19(19):
pubmed: 36231811
Psychotherapy (Chic). 2022 Jun;59(2):261-270
pubmed: 34990161
Sci Rep. 2014 Jul 04;4:5569
pubmed: 24993798
Cancer J. 2008 Nov-Dec;14(6):369-74
pubmed: 19060601
Front Psychol. 2020 Nov 02;11:580979
pubmed: 33224072
Front Psychol. 2021 Jun 09;12:647432
pubmed: 34177701
Eur J Cancer Care (Engl). 2008 Mar;17(2):157-66
pubmed: 18302653
Psychol Health. 2019 Jan;34(1):44-63
pubmed: 30516396
Front Psychiatry. 2022 Jun 16;13:859604
pubmed: 35782420
J Natl Cancer Inst. 2021 Nov 2;113(11):1495-1505
pubmed: 34057469
Acta Oncol. 2017 Feb;56(2):314-320
pubmed: 28093034
Support Care Cancer. 2022 Mar;30(3):2829-2837
pubmed: 34845503
Psychooncology. 2013 May;22(5):978-86
pubmed: 22674873
Am Psychol. 1989 Mar;44(3):513-24
pubmed: 2648906
Support Care Cancer. 2014 Mar;22(3):705-12
pubmed: 24193220
J Psychosoc Oncol. 2020 Mar-Apr;38(2):156-170
pubmed: 31625826
Psychooncology. 1997 Jun;6(2):95-105
pubmed: 9205967
Cancer Nurs. 2022 Sep-Oct 01;45(5):406-415
pubmed: 34560707
Psychooncology. 2013 Jan;22(1):1-11
pubmed: 22232030
Oncotarget. 2017 May 30;8(22):36800-36811
pubmed: 28404938
Eur J Cancer Care (Engl). 2019 Sep;28(5):e13113
pubmed: 31180170
Cancer Med. 2018 Oct;7(10):4980-4992
pubmed: 30187678
Psychooncology. 2011 Mar;20(3):302-12
pubmed: 20878830
Clin J Oncol Nurs. 2016 Dec 1;20(6):E155-E161
pubmed: 27857253
J Sch Psychol. 2010 Feb;48(1):5-37
pubmed: 20006986
J Psychosom Res. 2013 Apr;74(4):354-60
pubmed: 23497839
J Clin Oncol. 2009 Dec 20;27(36):6172-9
pubmed: 19884548
Psychooncology. 2018 Jan;27(1):295-301
pubmed: 28727897
Psychooncology. 2019 Oct;28(10):2033-2041
pubmed: 31364222
Cancer. 2022 Jan 15;128(2):335-343
pubmed: 34614212
J Cancer Surviv. 2013 Sep;7(3):300-22
pubmed: 23475398
Psychooncology. 2017 Oct;26(10):1444-1454
pubmed: 27246348
Integr Cancer Ther. 2016 Jun;15(2):175-82
pubmed: 26420778
Health Psychol. 2016 Jan;35(1):1-9
pubmed: 26030308
Clin Breast Cancer. 2019 Jun;19(3):165-177
pubmed: 30952546
Psychol Assess. 2018 Apr;30(4):486-499
pubmed: 28504538
Support Care Cancer. 2016 Aug;24(8):3265-8
pubmed: 27169703
Gynecol Oncol. 2007 Feb;104(2):381-9
pubmed: 17027072
Am J Transl Res. 2022 Jul 15;14(7):4804-4811
pubmed: 35958474
BMC Cancer. 2022 Apr 15;22(1):414
pubmed: 35428224
Health Psychol. 2016 Dec;35(12):1329-1333
pubmed: 27175578
Breast Care (Basel). 2019 Dec;14(6):344-353
pubmed: 31933579
J Pain Symptom Manage. 2020 Aug;60(2):381-389
pubmed: 32105790
Sch Inq Nurs Pract. 2001 Fall;15(3):277-94
pubmed: 11871585
Psychooncology. 2020 Nov;29(11):1835-1841
pubmed: 32720375
Psychooncology. 2009 Jan;18(1):71-8
pubmed: 18613299
Body Image. 2018 Dec;27:21-31
pubmed: 30121489
Psychooncology. 2012 Feb;21(2):203-10
pubmed: 22271541
Psychooncology. 2019 Sep;28(9):1781-1790
pubmed: 31206917
Support Care Cancer. 2009 Mar;17(3):241-51
pubmed: 18414902
Support Care Cancer. 2015 Jul;23(7):2033-43
pubmed: 25524004

Auteurs

Gabriella Bentley (G)

School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.

Osnat Zamir (O)

School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.

Rawan Dahabre (R)

School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.

Shlomit Perry (S)

School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.

Evangelos C Karademas (EC)

Department of Psychology, University of Crete and Foundation for Research and Technology, 70013 Heraklion, Greece.

Paula Poikonen-Saksela (P)

Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, 00100 Helsinki, Finland.

Ketti Mazzocco (K)

Department of Oncology and Hemato-Oncology, University of Milan, 20139 Milan, Italy.
Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20139 Milan, Italy.

Berta Sousa (B)

Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, 1400-038 Lisboa, Portugal.

Ruth Pat-Horenczyk (R)

School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.

Classifications MeSH